Message From the Editor-in-Chief
Cancer cachexia: definitions, outcomes, and treatments
Annals of Palliative Medicine
2019;
8
(1)
:E1-E3
.
(25 January 2019)
Preface
A review of cachexia: a tribute to Ken Fearon
Annals of Palliative Medicine
2019;
8
(1)
:1-2
.
(25 January 2019)
Review Article
Cancer cachexia is defined by an ongoing loss of skeletal muscle mass
Annals of Palliative Medicine
2019;
8
(1)
:3-12
.
(25 January 2019)
Lipid metabolism in cancer cachexia
Annals of Palliative Medicine
2019;
8
(1)
:13-23
.
(25 January 2019)
Measuring cachexia—diagnostic criteria
Annals of Palliative Medicine
2019;
8
(1)
:24-32
.
(25 January 2019)
Health-related quality of life across cancer cachexia stages
Annals of Palliative Medicine
2019;
8
(1)
:33-42
.
(25 January 2019)
What are the criteria for response to cachexia treatment?
Annals of Palliative Medicine
2019;
8
(1)
:43-49
.
(25 January 2019)
A hunger for hunger: a review of palliative therapies for cancer- associated anorexia
Annals of Palliative Medicine
2019;
8
(1)
:50-58
.
(25 January 2019)
Combination therapy in cachexia
Annals of Palliative Medicine
2019;
8
(1)
:59-66
.
(25 January 2019)
Anti-cytokines in the treatment of cancer cachexia
Annals of Palliative Medicine
2019;
8
(1)
:67-79
.
(25 January 2019)
Prokinetics and ghrelin for the management of cancer cachexia syndrome
Annals of Palliative Medicine
2019;
8
(1)
:80-85
.
(25 January 2019)
Sarcopenia associated with chemotherapy and targeted agents for cancer therapy
Annals of Palliative Medicine
2019;
8
(1)
:86-101
.
(25 January 2019)
News
Annals of Palliative Medicine is now indexed in Science Citation Index Expanded (SCIE)
Annals of Palliative Medicine
2019;
8
(1)
:102-103
.
(25 January 2019)
Disclosure:
The focused issue “Update on Cancer Cachexia in Memory of Ken Fearon” was commissioned by the editorial office, Annals of Palliative Medicine without any sponsorship or funding. Mellar P. Davis and Eduardo Bruera served as the unpaid Guest Editors for the focused issue.
